Jean-Jacques A.P. Mention, PhD

Chief Business Officer
  • chief business officer

Jean-Jacques brings more than 12 years of research in immunology and in virology at INSERM Paris, King’s College London and Institut Pasteur Paris, with a teaching experience in Biochemistry and Enzymology at the University of Versailles Saint-Quentin-en-Yvelines.

After his career of Researcher, Jean-Jacques A. P. Mention started his Business Development career at AXENIS in 2015 (start-up and spin-off of Institut Pasteur) as a Director of Business Development, on a new humanized mouse model as a tool for fundamental, clinical, therapeutic and pharmaceutical research for which he is the co-inventor.

He became in 2019 Head of Business development & Scientific Consulting at GenOway until he joined OSE Immunotherapeutic as Director of Business Development before becoming Chief Business Officer.


Jean-Jacques A. P. Mention holds a PhD in Immunology (Necker-Enfants Malades Hospitals Faculty of Sciences, Paris).